Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Anti-malaria drug resistance spreading to India
Mosquito
Millions of lives will be at risk if the resistance spreads from Asia to the African sub-continent, or emerges in Africa independently.

Resistance to artemisinin more widespread than previously thought

Resistance to the anti malaria drug artemisinin is more widespread than previously thought, according to a study published in Lancet Infectious Diseases.

Resistance to the drug is established in Myanmar, Burma, and is now just 25km away from the border of India.  The resistance follows the same path from Southeast Asia to the Indian subcontinent as seen in the past with other antimalarial medicines.

The scientists say that the spread of malaria parasites that are resistant to artemisinin into neighbouring India
would be a serious threat to the global control and eradication of malaria. They add that millions of lives will be at risk if the resistance spreads from Asia to the African sub-continent, or emerges in Africa independently.

The study was led by Dr Kyaw Myo Tun of the Defence Services Medical Research Centre in Myanmar, and was coordinated by the Mahidol - Oxford Tropical Medicine Research Unit (MORU) in Bangkok, Thailand.

Dr Charles Woodrow from MORU and senior author of the study at Oxford University, said: "Myanmar is considered the frontline in the battle against artemisinin resistance as it forms a gateway for resistance to spread to the rest of the world.

"With artemisinins we are in the unusual position of having molecular markers for resistance before resistance has spread globally. The more we understand about the current station in the border regions, the better prepared we are to adapt and implement strategies to overcome the spread of further drug resistance."

Professor Mike Turner, head of infection and immunobiology at the Wellcome Trust, added: "Drug resistant malaria parasites in the 1960s originated in Southeast Asia and from there spread through to Myanmar to India, and then to the rest of the world where it killed millions of people.

"The new research shows that history is repeating itself with parasites resistant to artemisinin drugs, the mainstay of modern malaria treatment, now widespread in Myanmar. We are facing the imminent threat of resistance spreading into India, with thousands of lives at risk."


The study, Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker by Tun et, al is published in Lancet Infectious Diseases.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
RCVS Regional Question Time heads to Edinburgh

The RCVS is to bring its Regional Question Time (RQT) to Edinburgh for 2026.

The event will take place at Novotel Edinburgh Park in Edinburgh on Wednesday, 20 May 2026.

It will begin with supper and drinks at 6.30pm, with an evening programme from 7.30pm. This will start with an update on RCVS' activities, followed by questions and answers with representatives.

RCVS is encouraging an 'open dialogue', in which queries can be raised in a friendly, informal environment.

While discussions are expected to be audience-led, the RQT is expected address major issues including the VSA, the CMA's remedy package and the VN Vision project.

Tim Parkin, RCVS president, said: "It's an important time for the professions, and I'm looking forward to meeting colleagues in Scotland as we navigate this period of change together so we can come out stronger."

Tickets can be booked here.